Kapila Ratnam
Partner @ NewSpring
Greater Philadelphia Area, United States
Kapila Ratnam is a private equity investor at NewSpring in Greater Philadelphia Area focused on Health Care and Biopharma. Kapila Ratnam - Partner @ NewSpring
- Total investments:
- 6
- Last investment:
- Lead investor:
- 83%
Last updated:
For AI agents: llms.txt
Industries Kapila Ratnam invests in
Stages Kapila Ratnam invests in
Countries Kapila Ratnam invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 3 (50%)
- Biopharma 2 (33%)
- Biotechnology 2 (33%)
- Manufacturing 2 (33%)
- Pharmaceutical 2 (33%)
Stage
- Private Equity 3 (50%)
- Series A 2 (33%)
- Venture - Series Unknown 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Kincell Bio collaborates with cell therapy developers by using considerable scientific experience and industry understanding. | $22M / Venture - Series Unknown / May 15, 2025 | ||
| AeroSafe Global develops and produces aerogels and related materials for temperature-sensitive shipping needs in the United States. Its products are used in various thermal insulation applications to transport biomedical, pharmaceutical, and other temperature-sensitive products. The company provides a reliable, simple, and sustainable temperaturesensitive supply chain solutions to the world’s leading biopharma companies.AeroSafe Global delivers cold-chain services for the biopharma industry that results in zero temperature excursions for every client, every product, every time. With proprietary packaging, logistics, and operational services, the company builds customized solutions that ensure the safe delivery of temperature-sensitive biopharmaceuticals. | $78M / Private Equity / Aug 29, 2023 | ||
| InHomeTherapy is a provider of at-home-based therapy and rehabilitation services for patients. The company is improving the health and well-being of patients by allowing them to rehabilitate in the safety and comfort of their homes. InHomeTherapy is based in King of Prussia, PA. | $22M / Series A / Sep 28, 2022 | ||
| BRC Healthcare owns and operates specialty behavioral health and addiction treatment facilities, programs, and services that encompass the complete continuum and all levels of care. The BRC Healthcare portfolio includes a growing list of industry-leading programs best known for their outstanding reputation and dedication to providing individualizedclinical care. The BRC Healthcare management team is committed to providing and expanding the highest-quality accredited behavioral healthcare services to the clients and families who need real change in their lives. | Private Equity / Apr 09, 2020 | ||
| Vybe operates community-based urgent care centers that provide convenient treatment for a broad range of illnesses and injuries. | Private Equity / May 10, 2018 | ||
| Paragon Bioservices is an industry-leading, private-equity backed contract development and manufacturing organization (CDMO) whose focus is the development and manufacturing of cutting-edge biopharmaceuticals. Paragon aims to build strong client partnerships with the world’s best biotech and pharma companies, focusing on transformativetechnologies, including gene therapies (AAV), next-generation vaccines, oncology immunotherapies (oncolytic viruses and CAR-T cell therapies), therapeutic proteins, and other complex biologics. The Company’s customer base has also transitioned from primarily substantial government contracts to now focus almost 100% on commercial activity servicing the biotech marketplace. The Company has retained Paragon’s core scientific talent while expanding its leadership team with new key senior hires who have a proven track record in GMP manufacturing. Each member of the current leadership team has over 20 years of industry experience and serves as the Company’s foundation to build a dominant CDMO in Maryland. Paragon now provides complete manufacturing services from process development and clinical manufacturing through commercial launch at its new 150,000 ft2 facility. | $13M / Series A / Oct 28, 2014 |
Co-Investors
Peloton Equity
2 deals together
Camden Partners
1 deal together
Escalate Capital Partners
1 deal together
Flexstone Partners
1 deal together
Hamilton Lane
1 deal together
Kineticos Life Sciences
1 deal together
About NewSpring
NewSpring Capital is a private equity firm that seeks to invest in business services, enterprise and infrastructure technology, security, and business intelligence sectors.
NewSpring Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anne Vazquez
General Partner
|
|||
Brian Kim
Growth Equity Investor & Partner
|
|||
Glenn Rieger
General Partner
|
|||
Hart Callahan
Partner
|
|||
|
Kapila Ratnam
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Kapila Ratnam invest in?
Kapila Ratnam invests primarily in Health Care, Biopharma and Biotechnology startups, most often at Private Equity and Series A stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Kapila Ratnam?
Public channels for Kapila Ratnam include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Kapila Ratnam last invest?
The most recent investment recorded for Kapila Ratnam closed in May 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
